Skip to Content
You are currently on the new version of our website. Access the old version .
  • Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.

Journal of Market Access & Health Policy, Volume 11, Issue 1

2023 January - 33 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (33)

  • Essay
  • Open Access
1 Citations
811 Views
13 Pages

Discounting Health Gain: A Different View

  • Baudouin Standaert and
  • Olivier Ethgen

ABSTRACT At least since the Age of Enlightenment, good health has been a tenet for society. Healthy societies could learn better, work harder, improve their wealth, and live longer. Today societies focus on life expectancy, as we value long and heal...

  • Article
  • Open Access
10 Citations
1,506 Views
12 Pages

Patient Perceptions of Copay Card Utilization and Policies

  • Dimika Cavalier,
  • Bridget Doherty,
  • Gabrielle Geonnotti,
  • Aarti Patel,
  • Wesley Peters,
  • Steven Zona and
  • Lisa Shea

ABSTRACT Background: Copay cards are intended to mitigate patient out-of-pocket (OOP) expenses. This qualitative, exploratory focus group study aimed to capture patient perceptions of copay cards and copay adjustment programs (CAPs; insurers’ accumu...

  • Article
  • Open Access
3 Citations
1,782 Views
14 Pages

Ivabradine in Patients with Heart Failure: A Systematic Literature Review

  • Zeba M. Khan,
  • Jean Baptiste Briere,
  • Elzbieta Olewinska,
  • Fatma Khrouf and
  • Mateusz Nikodem

ABSTRACT Background: Heart failure is a chronic disease linked with significant morbidity and mortality, and uncontrolled resting heart rate is a risk factor for adverse outcomes. This systematic literature review aimed to assess the efficacy, safet...

  • Article
  • Open Access
1 Citations
1,032 Views
11 Pages

Inappropriate Dosing of Direct Oral Anticoagulants: Findings from a Clinical Vignette Study and Physician Survey

  • Ahmet Fuat,
  • Emmanuel Ako,
  • David Hargroves,
  • Douglas Holden,
  • Amrit Caleyachetty,
  • Matthew Carter,
  • James Harris,
  • Carol Roberts,
  • Nnanyelu Nzeakor and
  • Helen Williams
  • + 1 author

ABSTRACT Objective: Direct oral anticoagulants (DOACs) are first-line therapy for stroke prevention for 1.4 million atrial fibrillation (AF) patients in the UK. However, the rates of DOAC dosing below evidence-based recommendations are estimated bet...

  • Article
  • Open Access
1,322 Views
11 Pages

Observational Study on the Therapeutic Management and Economic Burden of Adult Patients with Moderate to Severe Plaque Psoriasis in France—The POP Study

  • A. P. Villani,
  • N. Quiles Tsimaratos,
  • A. Crochard,
  • A. Gherardi,
  • A. Panes,
  • A. Schmidt,
  • M. Hueber Kollen and
  • I. Borget

ABSTRACT Background: Data on the therapeutic management and healthcare cost of moderate to severe psoriasis in France are scarce. Objective: To assess the therapeutic management and economic burden of patients with moderate to severe psoriasis. Sett...

  • Article
  • Open Access
873 Views
8 Pages

ABSTRACT Objectives: To obtain real-world data on rational drug use, pharmacoeconomic regarding women’s and children’s health and the benefits of Hainan free trade port (HFTP) health policies, we retrospectively investigated drug indicators, prescri...

  • Meeting Report
  • Open Access
884 Views
11 Pages

Rule of Prevention: A Potential Framework to Evaluate Preventive Interventions for Rare Diseases

  • Eddie Gibson,
  • Daniel A. Ollendorf,
  • Steven Simoens,
  • David E Bloom,
  • Federico Martinón-Torres,
  • David Salisbury,
  • Johan Louis Severens,
  • Mondher Toumi,
  • Daniel Molnar and
  • Najida Begum
  • + 2 authors

Background: The benefits of preventive interventions lack comprehensive evaluation in standard health technology assessments (HTA), particularly for rare and transmissible diseases. Objective: To identify possible considerations for future HTA using...

  • Review
  • Open Access
81 Citations
6,181 Views
7 Pages

Rapid Literature Review: Definition and Methodology

  • Beata Smela,
  • Mondher Toumi,
  • Karolina Świerk,
  • Clement Francois,
  • Małgorzata Biernikiewicz,
  • Emilie Clay and
  • Laurent Boyer

ABSTRACT Introduction: A rapid literature review (RLR) is an alternative to systematic literature review (SLR) that can speed up the analysis of newly published data. The objective was to identify and summarize available information regarding differ...

  • Review
  • Open Access
7 Citations
1,990 Views
17 Pages

Pharmaceutical Pricing and Reimbursement Policies in Algeria, Morocco, and Tunisia: Comparative Analysis

  • Hajer Dahmani,
  • Ines Fradi,
  • Leila Achour,
  • Mondher Toumi and
  • Maghreb Research Group

Objectives: In this paper, we outline and compare pharmaceutical pricing and reimbursement policies for in-patent prescription medicines in three Maghreb countries, Algeria, Morocco, and Tunisia, and explore possible improvements in their pricing and...

  • Article
  • Open Access
11 Citations
1,236 Views
11 Pages

Systematic Literature Reviews over the Years

  • Beata Smela,
  • Mondher Toumi,
  • Karolina Świerk,
  • Konrad Gawlik,
  • Emilie Clay and
  • Laurent Boyer

ABSTRACT Purpose: Nowadays, systematic literature reviews (SLRs) and meta-analyses are often placed at the top of the study hierarchy of evidence. The main objective of this paper is to evaluate the trends in SLRs of randomized controlled trials (RC...

  • Article
  • Open Access
802 Views
16 Pages

Budget and Health Impact of Switching Eligible Patients with Atrial Fibrillation to Lower- Dose Dabigatran

  • Tanja Fens,
  • Lisa de Jong,
  • Bregt Kappelhoff,
  • Cornelis Boersma and
  • Maarten J. Postma

ABSTRACT Objectives: To assess the comparative budget and health impact of lower-dose dabigatran versus reduced doses of apixaban and rivaroxaban in atrial fibrillation (AF) patients eligible for a lower-/reduced-dose due to individual patient chara...

  • Article
  • Open Access
2 Citations
807 Views
11 Pages

Budget Impact Analysis for Avatrombopag in the Treatment of Chronic Primary Immune Thrombocytopenia in Adult Patients Refractory to Other Treatments

  • Andrea Aiello,
  • Elisa Elena Mariano,
  • Mariangela Prada,
  • Cristina Teruzzi,
  • Nicoletta Martone,
  • Stefano Capri,
  • Giuseppe Carli and
  • Sergio Siragusa

ABSTRACT Introduction: Primary immune thrombocytopenia is a rare autoimmune disease characterised by a decreased platelet count resulting in an increased risk of bleeding events and even life-threatening haemorrhages. Thrombopoietin receptor agonist...

  • Article
  • Open Access
1,216 Views
7 Pages

The Impact of Amortization of Gene Therapies Funding on the Results and Conclusions of CEMs and BIMs

  • Hubert Polek,
  • Justyna Janik,
  • Ewelina Paterak,
  • Monique Dabbous,
  • Michał Pochopień and
  • Mondher Toumi

ABSTRACT Background: Gene replacement therapy (GRT) is a treatment method used to combat or prevent various diseases. Its high one-off cost constitutes a major obstacle for successful market access. This paper aims to assess and discuss the applicab...

  • Review
  • Open Access
4 Citations
862 Views
20 Pages

ABSTRACT Purpose: Remarkable progress in healthcare technology has recently been made alongside changes in concepts related to drugs and medical devices. It is speculated that this progress benefits not only patients but also healthcare professional...

  • Article
  • Open Access
3 Citations
863 Views
6 Pages

Economic Analysis of Allogeneic Hematopoietic Stem Cell Transplantation in the Bone Marrow Transplant Center of Tunisia

  • Leila Achour,
  • Chema Drira,
  • Mohamed Zied Sboui,
  • Ikram Fazaa,
  • Mohamed Ali Soussi,
  • Senda Hammami,
  • Tarek Ben Othman and
  • Myriam Razgallah Khrouf

Introduction: New procedures and diagnostic tests in hematopoietic stem cell transplantation (HSCT) are associated with a significant increase in costs. The last cost estimate of allogeneic HSCT done in Tunisia was in 1996 and concerned only direct m...

  • Article
  • Open Access
8 Citations
1,981 Views
14 Pages

Assessing the Value of Delandistrogene Moxeparvovec (SRP-9001) Gene Therapy in Patients with Duchenne Muscular Dystrophy in the United States

  • Alexa C. Klimchak,
  • Lauren E. Sedita,
  • Louise R. Rodino-Klapac,
  • Jerry R. Mendell,
  • Craig M. McDonald,
  • Katherine L. Gooch and
  • Daniel C. Malone

Background: Delandistrogene moxeparvovec (SRP-9001) is an investigational gene therapy that may delay progression of Duchenne muscular dystrophy (DMD), a severe, rare neuromuscular disease caused by DMD gene mutations. Early cost-effectiveness analys...

  • Article
  • Open Access
16 Citations
1,270 Views
12 Pages

The Role of Stakeholder Involvement in the Evolving EU HTA Process: Insights Generated through the European Access Academy’s Multi-Stakeholder Pre-Convention Questionnaire

  • Lauren Van Haesendonck,
  • Jörg Ruof,
  • Thomas Desmet,
  • Walter Van Dyck,
  • Steven Simoens,
  • Isabelle Huys,
  • Rosa Giuliani,
  • Mondher Toumi,
  • Christian Dierks and
  • Elaine Julian
  • + 13 authors

ABSTRACT Involvement of all relevant stakeholders will be of utmost importance for the success of the developing EU HTA harmonization process. A multi-step procedure was applied to develop a survey across stakeholders/collaborators within the EU HTA...

  • Article
  • Open Access
6 Citations
2,385 Views
11 Pages

Access to Innovative Drugs and the National Reimbursement Drug List in China: Changing Dynamics and Future Trends in Pricing and Reimbursement

  • Bérengère Macabeo,
  • Liam Wilson,
  • Jianwei Xuan,
  • Ruichen Guo,
  • Petar Atanasov,
  • Linda Zheng,
  • Clement François and
  • Philippe Laramée

ABSTRACT Background and objectives: Multiple reforms aimed at improving the Chinese population’s health have been introduced in recent years, including several designed to improve access to innovative drugs. We sought to review current factors affec...

  • Article
  • Open Access
3 Citations
747 Views
11 Pages

ABSTRACT Background: Perianal fistula (PF), a complication of Crohn’s disease (CD), affects health-related quality of life (QOL). Objective: To elucidate QOL of health states corresponding to different stages of PF associated with CD in Japan. Metho...

  • Article
  • Open Access
5 Citations
871 Views
12 Pages

ABSTRACT Background: The evidence base of tisagenlecleucel is uncertain. Objective: To evaluate the cost-effectiveness of tisagenlecleucel. To conduct expected value of perfect information (EVPI) and partial EVPI (EVPPI) analyses. Study Design: A th...

  • Article
  • Open Access
754 Views
10 Pages

ABSTRACT Introduction: To ensure the sustainability of the AT access improvement, it is important that health system stakeholders have timely, analyzed information accessible for reference and decision-making support. In this study, we projected the...

  • Article
  • Open Access
4 Citations
771 Views
9 Pages

ABSTRACT Introduction: Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disease that significantly reduces occupational productivity and quality-of-life in affected patients. Italy has an estimated FMF prevalence of 1 in 60,000 pe...

  • Review
  • Open Access
27 Citations
1,795 Views
10 Pages

Introduction: The Indian healthcare system is evolving towards better healthcare implementation and coverage. However, even today, the health-care system faces several challenges, a few of which are yet to be addressed. The present review is aimed to...

  • Article
  • Open Access
40 Citations
1,838 Views
5 Pages

ABSTRACT Background: Artificial intelligence (AI) enables remote patient monitoring (RPM) which reduces costs by triaging patients to optimize hospitalization and avoid complications. The FDA regulates AI in medical devices and aims to ensure patien...

  • Article
  • Open Access
1 Citations
1,036 Views
5 Pages

Quantitative Revenue Estimates and Qualitative Assessments of Innovative Fundraising Sources for Treating Rare Diseases in Colombia

  • Surrey M Walton,
  • Wilson Mayorga,
  • Angela Rodríguez Narváez,
  • Maria Alejandra Chavez,
  • Natalia Cortés Guesguán,
  • Luis Durango and
  • Ludy Alexandra Parada

Background: Like many developing countries, Colombia faces difficulties in financing health-care services as well as programs for health promotion and health education and there is evidence that its health-care system is underperforming. Objective: T...

  • Article
  • Open Access
19 Citations
1,174 Views
11 Pages

Machine-Learning Prediction for Hospital Length of Stay Using a French Medico-Administrative Database

  • Franck Jaotombo,
  • Vanessa Pauly,
  • Guillaume Fond,
  • Veronica Orleans,
  • Pascal Auquier,
  • Badih Ghattas and
  • Laurent Boyer

ABSTRACT Introduction: Prolonged Hospital Length of Stay (PLOS) is an indicator of deteriorated efficiency in Quality of Care. One goal of public health management is to reduce PLOS by identifying its most relevant predictors. The objective of this...

  • Article
  • Open Access
8 Citations
1,013 Views
15 Pages

Cost-Effectiveness of Infant Hypoallergenic Formulas to Manage Cow’s Milk Protein Allergy in France

  • Ana Teresa Paquete,
  • Rui Martins,
  • Mark P. Connolly,
  • Marie Meulle,
  • Nítida Pastor,
  • Grégoire Benoist and
  • Patrick Tounian

Background: Clinician’s choice of hypoallergenic formulas in the first-line management of cow’s milk protein allergy (CMPA) should be informed by evidence on clinical efficacy and cost-effectiveness. Objective: We compare the cost-effectiveness of a...

  • Review
  • Open Access
2 Citations
606 Views
10 Pages

Purpose: The success of reverse total shoulder arthroplasty (RTSA) has expanded its use for a broader range of shoulder indications worldwide. Evidence regarding the relative efficacy and long-term safety of medical technologies used in RTSA is subje...

  • Article
  • Open Access
1 Citations
712 Views
9 Pages

The Burden of Hospitalisations for COVID-19 in France: A Study of All Cases in the National Insurance Claims Database in 2020

  • Claire Leboucher,
  • Cécile Blein,
  • Valérie Machuron,
  • Kelly Benyounes,
  • Katell Le lay,
  • Aurélie Millier,
  • Romain Supiot and
  • François Raffi

Background: The economic consequences of the recent COVID-19 pandemic were substantial. However, direct medical costs in France have not been determined. Objective: To describe patient characteristics, intensity of care, mortality, and direct medical...

  • Short Communication
  • Open Access
6 Citations
890 Views
7 Pages

The Association between Body Mass Index Groups and Metabolic Comorbidities with Healthcare and Medication Costs: A Nationwide Biobank and Registry Study in Finland

  • Aino Vesikansa,
  • Juha Mehtälä,
  • Katja Mutanen,
  • Annamari Lundqvist,
  • Tiina Laatikainen,
  • Tero Ylisaukko-oja,
  • Tero Saukkonen and
  • Kirsi H. Pietiläinen

ABSTRACT Background: The increasing prevalence of obesity imposes a significant cost burden on individuals and societies worldwide. Objective: In this nationally representative study, the association between body mass index (BMI) groups and the numb...

  • Article
  • Open Access
13 Citations
965 Views
12 Pages

Objectives: Since the initial release of biosimilars 18 years ago, regulations for their licensing have changed considerably; however, there is no global consensus on these regulations. Establishing harmonized regulatory guidelines for the approval o...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Mark. Access Health Policy - ISSN 2001-6689